Tonghua, Shanxi, China The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Tonghua.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Medical. Among the various public portfolio startups of the fund, we may underline POCTech Corporation For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Tonghua Dongbao Pharmaceutical, startups are often financed by LenoMed Medical, Legend Capital. The meaningful sponsors for the fund in investment in the same round are Tasly Great Health Industry Fund, Legend Capital, BioVenture.
| Fund Name | Location |
| 58 Aifang | - |
| Bay Street Ventures | - |
| Beichenxing Ziben | - |
| Blue Bay Science Capital | China, Guangdong, Shenzhen |
| Cenova Capital | - |
| CHINTONE | Beijing, Beijing, China |
| COMTURE | Japan, Tokyo |
| Financial Plus Credit Union | Iowa, United States, West Des Moines |
| FSS Investments, LLC | Louisiana, Slidell, United States |
| Gongqingcheng Runyuan Touzi | China, Jiangxi, Jiujiang |
| Hengtai Capital | China, Guangdong, Shenzhen |
| Kayon Partners | New City, New York, United States |
| Kotak Mutual Fund | - |
| Mask Network | China, Shanghai |
| MBC BioLabs | California, San Francisco, United States |
| Mozilla | California, Mountain View, United States |
| Qingchuang Investment | - |
| Seeweb Srl | Frosinone, Italy, Lazio |
| Water Street Healthcare Partners | Chicago, Illinois, United States |
| Yancey Bros. Co | Austell, Georgia, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Junhemeng Biopharmaceutical | $15M | 08 May 2024 | Hangzhou, Zhejiang, China | ||
POCTech Corporation | $15M | 14 Apr 2017 | Huzhou, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Junhemeng Biopharmaceutical | $15M | 08 May 2024 | Hangzhou, Zhejiang, China | ||
POCTech Corporation | $15M | 14 Apr 2017 | Huzhou, Zhejiang, China |
